• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Fecal microbiota transplantation improves remission rates in ulcerative colitis

byJason Nam, MDandDaniel Fisher
January 16, 2019
in Chronic Disease, Gastroenterology, Surgery
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. In this randomized controlled trial, patients who received a donor fecal microbiota transplant (FMT) had a higher rate of steroid-free remission at 8-weeks than those who a received autologous FMT.

2. Donor FMT was also associated with better clinical response and clinical remission.

Evidence Rating Level: 1 (Excellent)

Study Rundown: Ulcerative colitis (UC) is a chronic inflammatory bowel condition that is treated with anti-inflammatory medications but often results in breakthrough symptoms, increased colorectal cancer risk, and sometimes necessitates colectomy. Though some studies have implicated colonic bacteria as being tied to UC pathogenesis, it is unclear if Fecal Microbiota Transplant (FMT) would be a suitable treatment. In this randomized controlled trial, a 3-dose, 1-week induction course of donor FMT was more likely to induce steroid-free, clinical and endoscopic remission in patients with active UC at 8 weeks versus autologous FMT. Patients who underwent donor FMT also had improved clinical remission and response.

This study utilized an anaerobic method for processing donor FMTs, which may have contributed to the similar clinical effects to other studies using higher intensity regimens. However, limitations including small study size and only 8 weeks of follow up suggest that further investigation would be necessary to endorse FMT as an effective and safe treatment for UC.

Click to read the study in JAMA

Click to read an accompanying editorial in JAMA

RELATED REPORTS

Ustekinumab and adalimumab comparable in safety and efficacy for treatment of Crohn’s disease

Upadacitinib significantly improves clinical remission rate for moderately to severely active ulcerative colitis

Ozanimod effective for induction and maintenance therapy of ulcerative colitis

Relevant Reading: Findings From a Randomized Controlled Trial of Fecal Transplantation for Patients With Ulcerative Colitis

In-Depth [ randomized controlled trial]: 73 adults with active UC (total Mayo score of 3 to 10 points and endoscopic score >1) from 3 Australian centers with mild to moderately active UC were recruited. Stable dosing of UC maintenance therapy, 5-aminosalicylic acid, thiopurines and methotrexate, and biological agents, was required prior to therapy. Patients enrolled taking an oral dose of prednisone had a mandatory taper. At colonoscopy, 200mL of fecal suspension of either donor stool or autologous stool was delivered into the right colon. Patients who received donor FMT had greater steroid free remission rates at 8-weeks than those who received autologous FMT (Odds Ratio 5.0; CI95 1.2 to 20.1). The mean total Mayo score decreased in both groups at 8 weeks but was significantly greater in the donor FMT group: (autologous FMT -1.2; CI95 -1.9 to -0.5; donor FMT -3.5; CI95 -4.3 to -2.7). Clinical response, measured by a ≥3 point Mayo score reduction at 8 week and 12 months was observed more often in participants receiving donor FMT (55%) vs. autologous FMT (23%) (difference 32%; CI95 10% to 54%). Clinical remission as measured by a Simple Clinical Colitis Activity index score ≤2 at 8 weeks and 12 months was also observed often in participants receiving donor FMT (difference 30%; CI95 7% to 51%).

Image: PD

©2019 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: fecal transplantUlcerative Colitis
Previous Post

Disease modifying therapies likely to reduce conversion to secondary progressing multiple sclerosis

Next Post

Quick Take: Histopathologic Predictors of Survival and Recurrence in Resected Ampullary Adenocarcinoma: International Multicenter Cohort Study

RelatedReports

Thalidomide may be effective in refractory pediatric Crohn’s disease
Chronic Disease

Ustekinumab and adalimumab comparable in safety and efficacy for treatment of Crohn’s disease

June 21, 2022
Elective colectomy associated with improved survival in ulcerative colitis
Chronic Disease

Upadacitinib significantly improves clinical remission rate for moderately to severely active ulcerative colitis

June 14, 2022
Patient Basics: Ulcerative Colitis
Chronic Disease

Ozanimod effective for induction and maintenance therapy of ulcerative colitis

November 3, 2021
Elective colectomy associated with improved survival in ulcerative colitis
Chronic Disease

Filgotinib effectively induces and maintains clinical remission in patients with ulcerative colitis

July 9, 2021
Next Post
Quick Take: Histopathologic Predictors of Survival and Recurrence in Resected Ampullary Adenocarcinoma: International Multicenter Cohort Study

Quick Take: Histopathologic Predictors of Survival and Recurrence in Resected Ampullary Adenocarcinoma: International Multicenter Cohort Study

#VisualAbstract: Hybrid Minimally Invasive Esophagectomy for Esophageal Cancer

#VisualAbstract: Hybrid Minimally Invasive Esophagectomy for Esophageal Cancer

No long-term outcome differences between stenting versus surgery for carotid stenosis

Quick Take: Risk Prediction Tools to Improve Patient Selection for Carotid Endarterectomy Among Patients With Asymptomatic Carotid Stenosis

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Methamphetamine use associated with cardiovascular disease in hospitalized patients
  • Management of uncomplicated urinary tract infections amongst women in the United States Military Health System highly concordant with guidelines
  • Gout flares associated with a transient increase in subsequent risk of cardiovascular events
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.